<--- Back to Details
First PageDocument Content
Vaccines / Hepatitis B / Viruses / Post-exposure prophylaxis / Chronic / HBsAg / Medicine / Health / Hepatitis
Date: 2012-05-02 14:00:45
Vaccines
Hepatitis B
Viruses
Post-exposure prophylaxis
Chronic
HBsAg
Medicine
Health
Hepatitis

Hepatitis B Lab Data Entry and Investigation Business Rules

Add to Reading List

Source URL: epi.ncpublichealth.com

Download Document from Source Website

File Size: 53,37 KB

Share Document on Facebook

Similar Documents

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

DocID: 1vngt - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

DocID: 1vjI2 - View Document

APASL and CEVHAP Partnership: a Hepatitis-Free World November

DocID: 1vgwC - View Document

California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu

DocID: 1vf93 - View Document